NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
Back to search
Official data from USPTO
JELLAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
JELLAGEN
ST13
US500000079220506Class
1, 3, 5, 10
Filing
79220506
Registration
5784044
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
02/20/2026
Trademark type
Word
Nice classes
1, 3, 5, 10
Filing date
06/06/2017
Registration date
06/25/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2026
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
SUAREZ, MARIA VICTORIA
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Jellagen Limited
Representatives
Amy Brozenic Lathrop GPM LLP
Technical classification
Nice Classes
Class 1Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industry; chemicals other than pharmaceuticals used in fish and jellyfish tanks; chemicals other than pharmaceuticals used in fish and jellyfish farming; biological preparations for use in cell cultures other than for medical or veterinary use; fish and jellyfish meal fertiliser; collagen as a raw ingredient for manufacturing cosmetics; collagen used as a raw ingredient in the manufacture of cosmetics and as a cell culture media for scientific and research use
Class 3
Bleaching preparations; cleaningpolishingscouring and abrasive preparations; perfumeryessential oilscosmeticshair lotions; dentifrices; collagen preparation for cosmetic applications and cosmetic purposes; non-medicated skincare preparations namely moisturizerscreamsfacial creamsserumsmakeup removersfacial cleansers and tonersface masksscrubs and exfoliators; bath and shower gels not for medical purposes; deodorants for personal use; creamsmilkslotionsgels and powders for facebody and hands; cosmetic and make-up preparations; shampoos; gelsmoussesbalms and preparations for hairdressing and hair care; hair lacquers; hair dyes and bleaching preparations for hair; preparations for waving and setting hair; essential oils
Class 5
pharmaceutical preparations for guided tissue regeneration and cell culture for use in human and veterinary medicine; sanitary preparations for medical purposes; medical plasters and dressings; material for stopping teethdental wax; disinfectants; vascular grafts; implants comprising of living tissue; biological tissue cultures for medical and veterinary purposes; pharmaceutical preparations for use in tissue regeneration and transplantation; antiseptic preparations for wound care; tissue-regenerative pharmaceutical preparations; collagen for medical purposes; implants comprising living tissue for guided tissue regeneration; implantable materials comprising collagen or live tissue for use in guided tissue regeneration; medical adhesives for binding internal tissue; implantable subcutaneous drug delivery devices filed with pharmaceutical preparations for the treatment of neurological diseasesdiabetescancerheart diseaseliver diseaselung diseaseneoplastic diseasesinflammatory diseasesskin infectionspneumonia; implantable textile material to encourage the growth of tissue comprised primarily of collagen or live tissue; edible fish oils for pharmaceutical purposes; fish oil for medical purposes; fish meal for pharmaceutical purposes; live organs and tissues for surgical and medical purpose of nano-scaffolds; medical dressings of collagen sponges; collagen hydrogels for medical purposes
Class 10
dental apparatus and instrumentsnamely dental implantsdental inlaysdental onlaysdental capsdental bridgesimplant abutments for dental purposesprosthetic instruments for dental purposes; artificial limbseyes and teeth; orthopaedic articlesnamely orthopaedic hip prosthesesorthopaedicmedicalsurgical implants made of artificial materials; suture materials; medical implants made of artificial materials; cell culture instruments for medical usecollagen spongescell culture chambersdividersstrainersdishesscrapers and tubes; apparatus for blood analysis; artificial skincartilageimplantsligamentsjoints and surgical implants; artificial implants; artificial organs and implants; implantable nano-scaffolds comprising synthetic or non-living collagen for maintaining tissue contour; cornea shields; intra-cornea implants from synthetic or non-living collagen; supportive bandages of collagen sponges; medical and surgical scaffolds comprising synthetic or non-living collagen for tissue regenerationrepair and engineering and pharmaceutical and drug testing
Publications
History of USPTO decisions and trademark events.
47 publications found
C71T
CANCELLED SECTION 71
01/09/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/25/2024
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
07/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/18/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/30/2019
FIMP
FINAL DISPOSITION PROCESSED
09/30/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/25/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2019
PUBO
PUBLISHED FOR OPPOSITION
04/09/2019
GPNX
NOTIFICATION PROCESSED BY IB
04/05/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/20/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/20/2019
ALIE
ASSIGNED TO LIE
03/01/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/21/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/11/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/15/2018
GNFR
FINAL REFUSAL E-MAILED
08/15/2018
CNFR
FINAL REFUSAL WRITTEN
08/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/16/2018
ATRV
ATTORNEY REVIEW COMPLETED
06/22/2018
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
06/15/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/25/2018
RFNP
REFUSAL PROCESSED BY IB
02/16/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2018
RFRR
REFUSAL PROCESSED BY MPU
01/22/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2018
CNRT
NON-FINAL ACTION WRITTEN
01/10/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/16/2017
CNRT
NON-FINAL ACTION WRITTEN
12/15/2017
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
12/11/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/28/2017
CNRT
NON-FINAL ACTION WRITTEN
11/27/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2017
DOCK
ASSIGNED TO EXAMINER
11/17/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/16/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/09/2017
Continuous trademark protection
Get notified about every new filing that threatens JELLAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.